Revium Rx (RVRC) Liabilities and Shareholders Equity (2024 - 2025)
Revium Rx recorded quarterly Liabilities and Shareholders Equity of $8.3 million in Q4 2025, down 59.1% quarter-over-quarter from $20.3 million in Q4 2024, and down 59.1% year-over-year from $20.3 million in Q4 2024.
Revium Rx's Liabilities and Shareholders Equity history runs 2 years deep, the most recent figure standing at $8.3 million for Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 8.98 Bn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 6.21 Bn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 3.31 Bn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 728.77 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 1.12 Bn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 5.84 Bn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 1.02 Bn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 1.42 Bn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 2.00 Bn |
| 10 | Revium Rx | - | - | - | 8.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.30 Mn |
| Dec 31, 2024 | 20.28 Mn |